Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

SHA:688739 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,443	10,612	13,539	12,668	31,704	-
Market Cap Growth	-5.04%	-21.62%	6.87%	-60.04%	-	-
Enterprise Value	6,052	5,273	7,974	7,019	29,988	-
Last Close Price	27.80	25.01	30.57	27.77	68.12	-
PE Ratio	34.30	30.96	29.06	17.74	35.52	-
PS Ratio	6.85	6.33	7.74	6.98	15.18	-
PB Ratio	1.19	1.11	1.41	1.31	3.39	-
P/TBV Ratio	1.21	1.13	1.44	1.34	3.44	-
P/FCF Ratio	71.41	76.63	108.30	363.13	-	-
P/OCF Ratio	22.61	21.18	20.00	23.18	62.61	-
EV/Sales Ratio	3.62	3.15	4.56	3.87	14.36	-
EV/EBITDA Ratio	11.21	9.59	12.76	8.24	27.24	-
EV/EBIT Ratio	16.85	13.71	15.80	9.55	30.29	-
EV/FCF Ratio	37.76	38.08	63.79	201.20	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	-
Debt / EBITDA Ratio	0.03	0.03	0.03	0.03	0.02	-
Debt / FCF Ratio	0.09	0.11	0.16	0.63	-	-
Asset Turnover	0.17	0.17	0.17	0.18	0.29	0.49
Inventory Turnover	0.76	0.72	0.76	0.56	0.66	1.04
Quick Ratio	18.49	16.73	19.05	26.38	25.52	11.76
Current Ratio	20.02	18.01	20.32	28.23	26.98	13.32
Return on Equity (ROE)	3.46%	3.58%	4.84%	7.51%	13.25%	24.35%
Return on Assets (ROA)	2.22%	2.39%	3.13%	4.63%	8.67%	14.85%
Return on Capital (ROIC)	2.32%	2.50%	3.27%	4.82%	9.17%	16.17%
Return on Capital Employed (ROCE)	3.70%	4.00%	5.20%	7.50%	10.40%	23.00%
Earnings Yield	2.91%	3.23%	3.44%	5.64%	2.81%	-
FCF Yield	1.40%	1.31%	0.92%	0.27%	-0.01%	-
Dividend Yield	2.89%	3.20%	2.62%	3.60%	1.47%	-
Payout Ratio	98.74%	96.08%	89.35%	58.30%	-	24.49%
Buyback Yield / Dilution	0.93%	0.71%	0.37%	-9.48%	-1.77%	0.18%
Total Shareholder Return	3.82%	3.91%	2.99%	-5.88%	-0.30%	0.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.